-
1.PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM II OF L-MALIC ACID SALT OF SUNITINIB 有权
标题翻译: 制备硫酸铵的盐酸结晶形式II的方法公开(公告)号:US20130197242A1
公开(公告)日:2013-08-01
申请号:US13510986
申请日:2010-11-19
IPC分类号: C07D403/06
CPC分类号: C07D403/06
摘要: The present invention relates to stable crystalline Form II of L-malic acid salt of sunitinib and its preparation.
摘要翻译: 本发明涉及舒尼替尼的L-苹果酸盐的稳定的晶型II及其制备方法。
-
公开(公告)号:US20120220783A1
公开(公告)日:2012-08-30
申请号:US13496559
申请日:2010-09-16
申请人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
发明人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
IPC分类号: C07D403/06
CPC分类号: C07D403/06
摘要: The present invention relates to salts of sunitinib and their preparation.
摘要翻译: 本发明涉及舒尼替尼的盐及其制备方法。
-
公开(公告)号:US20130210885A1
公开(公告)日:2013-08-15
申请号:US13575424
申请日:2011-01-28
申请人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
发明人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
IPC分类号: C07D403/06
CPC分类号: C07D403/06
摘要: The present invention relates to crystalline forms of L-malic acid salt of sunitinib and its preparation. The crystalline forms of the present invention are designated as Form V and Form VI of L-malic acid salt of sunitinib. Formula (I).
摘要翻译: 本发明涉及舒尼替尼的L-苹果酸盐的结晶形式及其制备方法。 本发明的结晶形式称为舒尼替尼的L-苹果酸盐的V型和VI型。 式(I)。
-
4.PROCESS FOR THE DIRECT PREPARATION OF MALIC ACID SALT OF SUNITINIB 审中-公开
标题翻译: 用于直接制备SUNITINIB的恶唑酸的方法公开(公告)号:US20130123511A1
公开(公告)日:2013-05-16
申请号:US13582493
申请日:2011-02-25
申请人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
发明人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
IPC分类号: C07D403/06 , C07C51/41
CPC分类号: C07D403/06 , C07C51/412
摘要: The present invention relates to a process for the direct preparation of malic acid salt of sunitinib.
摘要翻译: 本发明涉及一种直接制备舒尼替尼苹果酸盐的方法。
-
5.Process for the preparation of crystalline form II of L-malic acid salt of sunitinib 有权
标题翻译: 舒尼替尼的L-苹果酸盐的晶型II的制备方法公开(公告)号:US08916716B2
公开(公告)日:2014-12-23
申请号:US13510986
申请日:2010-11-19
IPC分类号: C07D403/06
CPC分类号: C07D403/06
摘要: The present invention relates to stable crystalline Form II of L-malic acid salt of sunitinib and its preparation.
摘要翻译: 本发明涉及舒尼替尼的L-苹果酸盐的稳定的晶型II及其制备方法。
-
6.PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF L-MALIC ACID SALT OF SUNITINIB 审中-公开
标题翻译: 制备硫酸铵的结晶形式I的方法公开(公告)号:US20120271056A1
公开(公告)日:2012-10-25
申请号:US13508907
申请日:2010-11-12
申请人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
发明人: Sudhir Singh Sanwal , Saridi Madhava Dileep Kumar , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
IPC分类号: C07D209/46 , A61P1/00 , A61K31/4035
CPC分类号: C07D403/06
摘要: The present invention relates to a process for the preparation of crystalline Form I of the L-malic acid salt of sunitinib.
摘要翻译: 本发明涉及一种制备舒尼替尼的L-苹果酸盐的晶型I的方法。
-
-
-
-
-